Increased infiltration of the tumor boundary by CD8+ cells has been associated with effective clinical responses to melanoma (27) and are consistent with favorable increases in CD8+/FoxP3+ ratios previously observed in melanoma biopsy samples (40). The gene discussed is FOXP3; the disease is neoplasm.